SCM
ASBP

Saba Capital Management’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History

Saba Capital Management’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,002,496
Closed -$21M – 643
2023
Q1 		$21M Hold
2,002,496
– – 0.4% 37
2022
Q4 		$20.6M Buy
2,002,496
+35,235
+2% +$363K 0.28% 67
2022
Q3 		$19.9M Buy
1,967,261
+50
+0% +$507 0.22% 93
2022
Q2 		$19.6M Buy
+1,967,211
New +$19.6M 0.23% 82